6 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... over injectable agents ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
will vary with clinical ... non-OTC prolonging agent ... No pharmacologic ... (Haldol) - No pharmacologic ... CriticalCare #diagnosis #management
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... prolongation, alopecia ... Weaknesses: Limited clinical ... Coccidioidomycosis #pharmacology ... #management #treatment
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... prolongation, alopecia ... tolerable • Limited clinical ... #valleyfever #management ... comparison #table #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... as substantial clinical ... least 1 year (AI)—see ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... weeks or until clinically ... Histoplasmosis #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology